Marchex, Inc. (NASDAQ:MCHX) Expected to Post Quarterly Sales of $14.37 Million

Equities analysts predict that Marchex, Inc. (NASDAQ:MCHX) will post sales of $14.37 million for the current quarter, according to Zacks. Two analysts have made estimates for Marchex’s earnings, with the highest sales estimate coming in at $14.70 million and the lowest estimate coming in at $14.04 million. Marchex posted sales of $26.49 million in the same quarter last year, which suggests a negative year over year growth rate of 45.8%. The firm is expected to issue its next earnings report on Wednesday, November 3rd.

On average, analysts expect that Marchex will report full year sales of $53.60 million for the current financial year, with estimates ranging from $52.70 million to $54.50 million. For the next year, analysts anticipate that the firm will post sales of $57.20 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Marchex.

Marchex (NASDAQ:MCHX) last announced its earnings results on Thursday, August 5th. The technology company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.08. Marchex had a negative net margin of 22.26% and a negative return on equity of 19.67%. The firm had revenue of $14.01 million for the quarter, compared to analyst estimates of $13.12 million.

Separately, Zacks Investment Research raised shares of Marchex from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a research note on Tuesday, August 17th.

In other Marchex news, major shareholder Edenbrook Capital, Llc acquired 51,428 shares of the company’s stock in a transaction that occurred on Friday, August 27th. The shares were acquired at an average price of $3.06 per share, with a total value of $157,369.68. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have purchased 122,769 shares of company stock worth $374,646 in the last three months. 18.55% of the stock is currently owned by insiders.

A number of institutional investors have recently modified their holdings of MCHX. Russell Investments Group Ltd. raised its holdings in Marchex by 51.1% in the first quarter. Russell Investments Group Ltd. now owns 83,951 shares of the technology company’s stock worth $234,000 after buying an additional 28,396 shares during the last quarter. B. Riley Financial Inc. purchased a new position in shares of Marchex during the first quarter valued at approximately $4,360,000. Stifel Financial Corp purchased a new position in shares of Marchex during the first quarter valued at approximately $238,000. Dimensional Fund Advisors LP raised its holdings in shares of Marchex by 17.5% during the first quarter. Dimensional Fund Advisors LP now owns 163,493 shares of the technology company’s stock valued at $459,000 after purchasing an additional 24,339 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in shares of Marchex during the first quarter valued at approximately $62,000. 57.98% of the stock is owned by institutional investors and hedge funds.

NASDAQ:MCHX opened at $3.00 on Friday. Marchex has a one year low of $1.62 and a one year high of $3.67. The company’s 50-day simple moving average is $2.90 and its 200 day simple moving average is $2.87. The firm has a market capitalization of $124.25 million, a P/E ratio of -9.09 and a beta of 1.84.

Marchex Company Profile

Marchex, Inc operates as a conversational analytics and solutions company which helps businesses connect, drive, measure, convert callers into customers, and connects the voice of the customer to business. It offers Marchex call analytics platform, Marchex call marketplace and Marchex local leads products to automotive, travel and hospitality, telecommunications, insurance, home services, digital agencies, healthcare, education & careers, financial services, legal, real estate and senior living industries.

Featured Story: What is a put option?

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.